Brainlab technology is designed to support clinicians in treating patients with cancer and other diseases of the brain and body. With approximately 14500 systems at roughly 6300 hospitals in 122 countries, Brainlab is committed to the fight against cancer and advancing global access to consistency in treatment.

A pioneering technology company with a longstanding dedication to innovation in the fields of surgery and radiosurgery, Brainlab develops, manufactures and markets software-driven medical technology. Core products include information-guided surgery, precision radiation therapy and information and knowledge sharing that fosters interdisciplinary collaboration. Brainlab technology currently powers treatments in the fields of neurosurgery, radiosurgery/radiotherapy, ENT, CMF, spine and trauma

For more detailed information on products, please visit the technology and product pages.

See you at SIGN 2024